Potential drugs used in the antibody-drug conjugate (ADC) architecture for cancer therapy.
Yaghoubi S, Karimi MH, Lotfinia M, Gharibi T, Mahi-Birjand M, Kavi E, Hosseini F, Sineh Sepehr K, Khatami M, Bagheri N, Abdollahpour-Alitappeh M.
Yaghoubi S, et al.
J Cell Physiol. 2020 Jan;235(1):31-64. doi: 10.1002/jcp.28967. Epub 2019 Jun 18.
J Cell Physiol. 2020.
PMID: 31215038
Review.